Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.0B | 966.0M | 920.0M | 964.5M |
| Cost of revenue | 614.6M | 577.5M | 515.2M | 569.8M |
| Gross profit | 431.6M | 388.5M | 404.8M | 394.7M |
| Operating expense | ||||
| Research & development | 181.8M | 184.4M | 165.3M | 168.1M |
| Selling general and admin | 179.6M | 168.7M | 163.4M | 167.4M |
| Other operating expenses | — | — | — | — |
| Operating income | 64.6M | 29.8M | 70.5M | 53.0M |
| Non operating interest income | ||||
| Income | 13.9M | 11.5M | 11.8M | 13.6M |
| Expense | 19.6M | 20.2M | 20.1M | 21.8M |
| Other income expense | -2.4M | -4.9M | -3.4M | -3.6M |
| Pretax income | 56.5M | 16.3M | 58.9M | 41.2M |
| Tax provision | 13.3M | 8.6M | 20.6M | 9.4M |
| Net income | 43.2M | 7.7M | 38.2M | 31.8M |
| Basic EPS | 0.4 | 0.1 | 0.3 | 0.3 |
| Diluted EPS | 0.4 | 0.1 | 0.3 | 0.3 |
| Basic average shares | 121.7M | 122.3M | 122.6M | 123.8M |
| Diluted average shares | 124.0M | 124.4M | 125.2M | 125.7M |
| EBITDA | 109.1M | 70.4M | 111.0M | 95.6M |
| Net income from continuing op. | 43.2M | 7.7M | 38.2M | 31.8M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |